Search the Newsreel

DRTS Stock Gets A Pre-Market Boost – Retail Shrug Off Wider Q1 Loss Ahead Of Key Pancreatic Cancer Data Reveal This Week

SBC Medical Holdings earnings missed by $0.02, revenue topped estimates

SBC Medical Holdings (NASDAQ: SBC) reported second-quarter EPS of $0.10, missing analyst estimates by $0.02, but revenue came in at $49M, exceeding the consensus estimate of $45.37M. The company's stock is up 7.74% in the last three months but down -21.18% over the past …

Avita Medical Inc. (ASX:AVH) Share Price Remains Unchanged as Stock Trades Within Daily Range

NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9%

NeuroOne Medical Technologies Corporation reported strong fiscal Q3 2026 financial results, with product revenue increasing 16% year-over-year to $2.0 million and gross margins expanding to 59.9%. The company also announced $2.7 million in new product orders, received ISO 13485 Certification for international expansion, and …

Parabilis Medicines Q2 Loss Narrows; Shares Rise Pre-Bell

Parabilis Medicines reported a narrower Q2 net loss of $2.32 per share, with revenue reaching $148,000. Following this news, the company's shares experienced a rise in pre-bell trading. Parabilis Medicines, formerly FOG Pharmaceuticals, is a clinical-stage biopharmaceutical company focused on developing transformative medicines for …

Q3 EPS Estimate for Alpha Tau Medical Decreased by Analyst

HC Wainwright has lowered its Q3 2026 EPS estimate for Alpha Tau Medical (NASDAQ: DRTS) to a loss of $0.15 per share from $0.14, while maintaining a "Buy" rating and a $16 price target. The company recently reported a Q2 loss of $0.50 per …

Actinogen Medical Ltd (ASX: ACW) Share Price Steady as Stock Closes Flat

What is HC Wainwright's Estimate for DMAC Q3 Earnings?

Price to book forward of CalciMedica, Inc. – BOATS:CALC

The article provides a financial data point for CalciMedica, Inc. (CALC) related to its "Price to book forward" metric. It appears to be a stub or partial financial report from TradingView, indicating the company's market status and some basic financial information without further details …

Pro Medicus (ASX:PME) Expands Medical Imaging Software Globally Market Outlook

ROCKWELL MEDICAL, INC. 2026: Revenue $17.78M, EPS ($0.34) — 10-Q Summary

Rockwell Medical, Inc. (RMTI) reported its 2026 Q3 results with revenue of $17.78M, a net loss of ($1.17M), and diluted EPS of ($0.34). The company saw revenue growth driven by new Western U.S. accounts and improved gross margins due to operational efficiencies. Rockwell Medical …

Rockwell Medical (RMTI) lifts Q2 revenue, improves margins and executes reverse split

Rockwell Medical (RMTI) announced an 11% increase in Q2 2026 net sales to $17.8 million and improved gross margins to 18%, narrowing its net loss. The company also executed a 1-for-10 reverse stock split on July 1, 2026, to regain Nasdaq compliance. Despite a …

Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates

Parabilis Medicines: Q2 Earnings Snapshot

SBC Medical Group (SBC) Q2 2026: profit jumps, cash flow turns positive

SBC Medical Group reported strong Q2 2026 results with total revenues increasing to $49.19 million, up from $43.36 million a year prior, primarily driven by related-party revenues. The company saw a significant jump in net income attributable to shareholders, reaching $10.69 million compared to …

PARABILIS MEDICINES (PBLS) Stock News & Updates

Is Rockwell Medical Inc (RMTI) Undervalued After Q2 Earnings Mis

SBC Medical Q2 Revenue Rises 13% to $49.2 Million

SBC Medical Group Holdings (SBC) reported a 13% increase in Q2 2026 revenue, reaching $49.2 million, with net income rising significantly to $10.7 million compared to the prior year. The company's basic and diluted EPS also saw a substantial increase from $0.02 to $0.10. …

Themis Medicare reports consolidated net profit of Rs 24.61 crore in the June 2026 quarter

SBC Medical Group Holdings Inc Q2 2026: Revenue $49.19M, EPS $0.1— 10-Q Summary

SBC Medical Group Holdings Inc reported strong financial results for Q2 2026, with revenue reaching $49.19 million, a 13.4% increase year-over-year. Net income attributable to the company saw a significant rise of 335.0% to $10.69 million, resulting in diluted earnings per share of $0.10. …

Sisram Medical Sets Final 2025 Dividend and Clarifies 20% Israeli Withholding Tax

Sisram Medical Sets Record Date and Tax Terms for 2025 Final Dividend

Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates

Parabilis Medicines reported its second quarter 2026 financial results, highlighting significant progress in advancing zolucatetide for Wnt/β-catenin-driven diseases and expanding its Helicon™ platform through a collaboration with Regeneron. The company ended the quarter with a strong financial position of $1.1 billion in cash, cash …

Wasatch Advisors LP Buys 725,560 Shares of Journey Medical Corporation $DERM

Rockwell Medical reports Q2 2026 revenue $17.8M, gross margin 18%, narrows net loss

Beauty Farm Sets Board Meeting and Earnings Call for 2026 Interim Results

Rockwell Medical: Q2 Earnings Snapshot

The article "Rockwell Medical: Q2 Earnings Snapshot" provides a brief overview of Rockwell Medical's second-quarter earnings. The content is very minimal, indicating a lack of detailed information regarding the company's financial performance.

Rockwell Medical Announces Second Quarter 2026 Results

Rockwell Medical, Inc. (Nasdaq: RMTI) announced its financial and operational results for the second quarter and six months ended June 30, 2026, highlighting continued business momentum and progress towards its 2026 guidance. The company reported increased net sales and gross profit compared to the …

Strata Critical Medical, Inc. (SRTA) stock price, news, quote and history

China Resources Medical Sets August Board Meeting on Interim Results and Dividend

Rainmed Medical Sets Board Meeting to Approve 2026 Interim Results and Consider Dividend

Rockwell Medical expands Q2 gross margin to 18% on lower manufacturing costs

Wasatch Advisors LP Has $20.49 Million Stock Position in TransMedics Group, Inc. $TMDX

Wasatch Advisors LP reduced its stake in TransMedics Group (NASDAQ:TMDX) by 10.9% in the second quarter but still holds 308,434 shares valued at $20.49 million. The company's recent earnings showed a revenue beat but an EPS miss, leading to mixed analyst ratings with an …

MMSI Maintained by B of A Securities -- Price Target Raised to $97.00

B of A Securities maintained a neutral rating on Merit Medical Systems (MMSI) but raised its price target from $92.00 to $97.00. GuruFocus indicates MMSI is undervalued by 4.9% with a strong GF Score of 86/100, excelling in growth and valuation. While gurus show …

Royal Bank of Canada Purchases 179,418 Shares of Fresenius Medical Care AG & Co. KGaA $FMS

Royal Bank of Canada significantly increased its stake in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) by 479.2% in the first quarter, acquiring 179,418 additional shares. This brings their total holdings to 216,861 shares, valued at approximately $4.9 million. Despite the substantial purchase, …

OrbusNeich Reports Growth Across All Geographies in 2026 Interim Results